rs727504166
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000543.5(SMPD1):c.475T>C(p.Cys159Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000057 in 1,613,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C159Y) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPD1 | NM_000543.5 | c.475T>C | p.Cys159Arg | missense_variant | 2/6 | ENST00000342245.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPD1 | ENST00000342245.9 | c.475T>C | p.Cys159Arg | missense_variant | 2/6 | 1 | NM_000543.5 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250578Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135464
GnomAD4 exome AF: 0.0000588 AC: 86AN: 1461506Hom.: 0 Cov.: 34 AF XY: 0.0000440 AC XY: 32AN XY: 727036
GnomAD4 genome ? AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74386
ClinVar
Submissions by phenotype
Niemann-Pick disease, type A Pathogenic:3
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 21, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 25, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 22, 2017 | - - |
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 14, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jan 18, 2024 | This sequence change replaces cysteine, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 159 of the SMPD1 protein (p.Cys159Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with Niemann-Pick disease (PMID: 16434659, 17011332; Invitae). This variant is also known as C157R, c.463T>C (p.Cys155Arg) . ClinVar contains an entry for this variant (Variation ID: 167709). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 8407868). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 25, 2014 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 10, 2023 | - - |
Niemann-Pick disease, type B Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 04, 2023 | Variant summary: SMPD1 c.475T>C (p.Cys159Arg) results in a non-conservative amino acid change located in the Saposin B type domain (IPR008139) of the encoded protein sequence. This domain has been reported to have functional importance for ASM catalytic activity (Simonaro_2002). Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250578 control chromosomes (gnomAD). c.475T>C has been reported in the literature in individuals affected with Niemann-Pick disease type B and subsequently cited by others (e.g. McGovern_2004). These data indicate that the variant may be associated with disease. The variant has also been detected in individuals affected with Parkinsons's Disease, without strong evidence for causality (e.g. Robak_2017, Alcalay_2019). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in loss of catalytic activity (10%-<30% of normal activity) in vitro (Ida_1993). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Sphingomyelin/cholesterol lipidosis Pathogenic:1
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 22, 2020 | The p.Cys159Arg variant in SMPD1 (also known as p.Cys157Arg due to a difference in cDNA numbering) has been reported in at least 3 individuals with Niemann-Pick disease (PMID: 12369017, 16434659, 17011332) and has been identified in 0.010% (1/10348) of Ashkenazi Jewish chromosomes, 0.004% (1/24922) of African chromosomes, and 0.002% (3/128714) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs727504166). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also has also been reported in ClinVar (VariationID: 167709) as likely pathogenic by Counsyl and Integrated Genetics and as pathogenic by EGL Genetic Diagnostics. In vitro functional studies provide some evidence that the p.Cys159Arg variant may impact protein function (PMID: 8407868). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with a reported pathogenic variant and in an individual with Niemann-Pick disease increases the likelihood that the p.Cys159Arg variant is pathogenic (VariationID: 2993; 16434659). The p.Cys159Arg variant is located in a region of SMPD1 that is essential to protein folding and stability, suggesting that this variant is in a functional domain and supports pathogenicity (PMID: 12369017, 27725636). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on functional studies, its location in a disulfide bond in the saposin domain, and the presence of the variant in combination with another pathogenic variant. ACMG/AMP Criteria applied: PS3, PM2, PM1, PP3, PM3_supporting (Richards 2015). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at